3/31/2009, 8:08 AM (Source: GlobeNewswire)
Munich, Germany and Somerset, NJ, March 31, 2009 - Bavaria
Industriekapital AG, a German industrial holding company ("Bavaria"),
and Catalent Pharma Solutions today jointly announced the completion
of the purchase of Catalent's Osny, France, oral manufacturing
business by an affiliate of Bavaria. Terms of the transaction, which
is effective as of March 30th, were not disclosed.

The Osny business with annual sales of approximately Euro 25 million
provides cGMP development and manufacturing services for hormonal and
other high potent drugs in oral dose forms that are either approved
for commercial marketing or in clinical development. The business
expects to retain all 170 employees associated with the business as
of the closing, and to continue to serve all existing customers of
the business. The business will become known as "Osny Pharma SAS"
effective as of the closing.

Hans Magnus Andresen, Managing Director of BAVARIA, comments,
"BAVARIA is extremely excited about this acquisition. We have been
very impressed by the management and operating teams in Osny and look
forward to playing a vital part in the continuation of the site's
positive development. The site will focus strongly on keeping its
loyal customer base satisfied and continuously optimize its
production processes without losing its keen eye on delivering top
quality products. Osny Pharma SAS has long standing traditions in
this industry and is ideally positioned for continued growth -
organically as well as through additional acquisitions."

Ian Muir, Vice President and General Manager of Modified Release
Technologies for Catalent, said, "We are pleased that Bavaria has
acquired this business, as we believe they, along with the strong
local team in place, will continue to provide the facility's
customers the high degree of quality and compliance they have
received in the past. We also appreciate the commitment Bavaria has
demonstrated to the future of the business, and to the dedicated
employees at the site."

BAVARIA Industriekapital AG is an industrial holding company which
acquires low-profit companies throughout Europe. Through active
restructuring and revitalization management it ensures the long-term
success of the companies acquired. The majority of the stock of
BAVARIA Industriekapital AG is family-owned and the company has been
listed on the Entry Standard All Share Index of the German Stock
Exchange since 2006. At present BAVARIA Industriekapital AG has
holdings in nine companies and around 3,000 employees. In 2008 the
group turnover amounted to Euro 485 million and the group profit to
Euro 23 million.

For additional information about BAVARIA Industriekapital, please
visit our website at

We would be pleased to answer any further questions you may have:

BAVARIA Industriekapital AG
Svea Strohm
Bavariaring 24
80336 München

Phone: + 49 - (0)89/ 72 98 967-0
Fax: + 49 - (0)89/ 72 98 967-10

This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.